Brief: Heidelberg Pharma Raises EUR 14.4 Mln From Private Placement
April 28 (Reuters) - HEIDELBERG PHARMA AG WL6G.DE :
* SAID ON MONDAY IT RAISES EUR 14.4 MILLION FROM PRIVATE
PLACEMENT
* SAYS 2,679,961 SHARES WERE ALLOCATED TO THE MAIN INVESTOR
DIEVINI HOPP BIOTECH HOLDING GMBH & CO. KG AS WELL AS 141,000
SHARES TO INSTITUTIONAL INVESTORS AT A PRICE OF EUR 5.10 PER
SHARE
* CAPITAL MEASURE WILL INCREASE TOTAL NUMBER OF REGISTERED
SHARES
AFTER THE ISSUANCE TO 31,030,572
Source text for Eikon: ID:nEQ8nRpRqa
Further company coverage: WL6G.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Heidelberg Pharma AG
See all newsBrief: Heidelberg Pharma And Huadong Medicine Receive Nmpa Approval For Hdp-101 Trial In China
Germany's Heidelberg Pharma H1 sales revenue surges, driven by milestone payments
Brief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty